3 Stocks Raising The Health Services Industry Higher

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 83 points (-0.5%) at 16,448 as of Tuesday, May 6, 2014, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,223 issues advancing vs. 1,760 declining with 164 unchanged.

The Health Services industry currently sits down 0.1% versus the S&P 500, which is down 0.4%. Top gainers within the industry include WellCare Health Plans ( WCG), up 5.4%, CareFusion ( CFN), up 1.7%, Hologic ( HOLX), up 1.6% and Varian Medical Systems ( VAR), up 0.9%. A company within the industry that fell today was Fresenius Medical Care AG & Co. KGaA ( FMS), up 2.8%.

TheStreet would like to highlight 3 stocks pushing the industry higher today:

3. Stryker Corporation ( SYK) is one of the companies pushing the Health Services industry higher today. As of noon trading, Stryker Corporation is up $0.52 (0.7%) to $79.35 on light volume. Thus far, 599,125 shares of Stryker Corporation exchanged hands as compared to its average daily volume of 1.7 million shares. The stock has ranged in price between $78.46-$79.43 after having opened the day at $78.60 as compared to the previous trading day's close of $78.83.

Stryker Corporation, together with its subsidiaries, operates as a medical technology company. The company operates in three segments: Reconstructive, MedSurg, and Neurotechnology and Spine. Stryker Corporation has a market cap of $29.5 billion and is part of the health care sector. The company has a P/E ratio of 38.5, above the S&P 500 P/E ratio of 17.7. Shares are up 4.9% year-to-date as of the close of trading on Monday. Currently there are 13 analysts who rate Stryker Corporation a buy, no analysts rate it a sell, and 10 rate it a hold.

TheStreet Ratings rates Stryker Corporation as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, expanding profit margins and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Stryker Corporation Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

2. As of noon trading, Medtronic ( MDT) is up $0.54 (0.9%) to $59.60 on light volume. Thus far, 1.5 million shares of Medtronic exchanged hands as compared to its average daily volume of 4.9 million shares. The stock has ranged in price between $58.90-$59.61 after having opened the day at $59.04 as compared to the previous trading day's close of $59.05.

Medtronic, Inc. manufactures and sells device-based medical therapies worldwide. The company operates in two segments, Cardiac and Vascular Group, and Restorative Therapies Group. Medtronic has a market cap of $58.8 billion and is part of the health care sector. The company has a P/E ratio of 16.7, below the S&P 500 P/E ratio of 17.7. Shares are up 2.9% year-to-date as of the close of trading on Monday. Currently there are 7 analysts who rate Medtronic a buy, no analysts rate it a sell, and 11 rate it a hold.

TheStreet Ratings rates Medtronic as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, reasonable valuation levels, good cash flow from operations and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Medtronic Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

1. As of noon trading, Express Scripts ( ESRX) is up $0.37 (0.6%) to $67.20 on average volume. Thus far, 3.5 million shares of Express Scripts exchanged hands as compared to its average daily volume of 5.7 million shares. The stock has ranged in price between $66.55-$67.42 after having opened the day at $66.83 as compared to the previous trading day's close of $66.83.

Express Scripts Holding Company provides a range of pharmacy benefit management (PBM) services primarily in the United States and Canada. The company offers healthcare management and administration services on behalf of its clients. Express Scripts has a market cap of $52.0 billion and is part of the health care sector. The company has a P/E ratio of 29.5, above the S&P 500 P/E ratio of 17.7. Shares are down 4.8% year-to-date as of the close of trading on Monday. Currently there are 15 analysts who rate Express Scripts a buy, no analysts rate it a sell, and 4 rate it a hold.

TheStreet Ratings rates Express Scripts as a buy. The company's strengths can be seen in multiple areas, such as its reasonable valuation levels, largely solid financial position with reasonable debt levels by most measures, notable return on equity and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Express Scripts Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

null

More from Markets

Carnival CEO Arnold Donald: China Will Become the Largest Cruise Market

Carnival CEO Arnold Donald: China Will Become the Largest Cruise Market

Red Robin Slumps After Earnings Miss

Red Robin Slumps After Earnings Miss

Owner of Moviepass Sees Stock Plummet

Owner of Moviepass Sees Stock Plummet

Tiffany & Co. Sees a Strong Market in Asia

Tiffany & Co. Sees a Strong Market in Asia

Stocks Finish Higher After Release of Fed Minutes

Stocks Finish Higher After Release of Fed Minutes